Nitto Denko Avecia will acquire Girindus America's oligonucleotide and small molecule API contract manufacturing business. Nitto Denko Avecia said the acquisition will allow it to offer customers an expanded range of manufacturing capabilities, as well as a second manufacturing facility for security of supply.
Nitto Denko Avecia
Wednesday 14 November 2012
Nitto Denko Avecia to acquire Girindus contract manufacturing business
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment